logo
Plus   Neg
Share
Email

After Market Hours: Beazer Homes, Nike Gain, Aurora Cannabis, Wave Life Sciences, Stitch Fix Slip

Beazer Homes USA, Inc. (BZH) - Shares of the homebuilder gained 9% in after-hours trading Tuesday after the company reported improvement in new orders for the first two months of the fourth quarter. Net new orders for the first two months of fourth quarter were up 37% year-over-year with a 26% increase in July and a 48% increase in August.

NIKE, Inc. (NKE) - Shares of the sports apparel retailer rose 11% in extended session Tuesday after its first quarter results trumped Wall Street estimates. Nike's profit rose to $1.52 billion or $0.95 per share from $1.37 billion or $0.86 per share last year. Revenues slipped 0.7% to $10.59 billion from $10.66 billion last year. Analysts polled by Thomson Reuters expected earnings of $0.47 per share on revenues of $9.14 billion.

Aurora Cannabis Inc. (ACB) - The Canadian marijuana company tanked 15% after the bell on Tuesday. Aurora said it has slipped from its top position in Canadian consumer market. The marijuana grower's fourth-quarter revenues slipped 5% to $72.1 million.

Wave Life Sciences Ltd. (WVE) - Shares of the company plunged 23% in after-hours trading Tuesday. Wave Life Sciences announced that it has commenced an public offering of its ordinary shares.

Stitch Fix Inc. - Shares of the company slipped sharply in the extended session Tuesday hurt largely by its fourth quarter results. Stitch Fix's revenues rose to $443.4 million from $432.1 million last year. The company posted a loss of $44.5 million or $0.44 per share, compared to a profit of $7.2 million or $0.07 per share last year.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Santa Cruz Bicycles LLC has recalled certain model year 2020 bicycles with aluminum frames citing fall risks, according to the U.S. Consumer Product Safety Commission. The recall involves about 2,900 units of model year 2020 Auminum Santa Cruz and Juliana Bicycles. In addition, about 216 were sold in Canada. AstraZeneca is mulling an additional global trial to confirm the 90% efficacy rate of its Covid-19 vaccine candidate at lower dosage, Bloomberg news quoted Chief Executive Officer Pascal Soriot as saying. In an interview, Soriot noted that instead of adding the trial to an ongoing U.S. process, the company might launch a fresh study to evaluate efficacy of lower dosage of its vaccine that perform U.S. airline Delta Air Lines, Inc. and its Italian codeshare partner Alitalia are planning to launch quarantine-free, COVID-free flights between U.S. and Europe through new testing protocols, starting in December. In a statement, Delta said it has signed deals with airports and governments eliminating quarantine requirements on COVID-tested flights connecting Atlanta and Rome.
Follow RTT